Engineered DNA polymerase variants
US12129495B2 · kind B2 · utility
0Cited by
131References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2022 |
| Grant date | Oct 29, 2024 |
| Priority date | — |
| Expiry date | Oct 14, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y207/07007
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure relates to engineered DNA polymerase polypeptides and compositions thereof, as well as polynucleotides encoding the engineered DNA polymerase polypeptides. The present disclosure also provides methods of using the engineered DNA polymerase polypeptides or compositions thereof for diagnostic and other purposes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.